COMMUNIQUÉS West-GlobeNewswire

RAMSAY GENERALE DE SANTE : nomination de Natalie Davis Présidente du Conseil d'Administration 26 juin 2025
26/06/2025
COMMUNIQUÉ DE PRESSE Paris, le 26 juin 2025 Le Conseil d’Administration de Ramsay Générale de Santé nomme Natalie Davis Présidente du Conseil Le Conseil d’administration réuni ce jour, annonce la nomination de Natalie [...]
Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of the Board
26/06/2025
PRESS RELEASE Paris, 26th June 2025 Ramsay Générale de Santé Board of Directors appoints Natalie Davis as Chairman of the Board At its meeting today, the Board of Directors announced the appointment of Natalie Davis as [...]
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
26/06/2025
Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for Triple-Negative Breast Cancer FLORHAM [...]
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
26/06/2025
Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansion Led successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova [...]
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
26/06/2025
Important Study Shows Vivos Technology to be a Safe and Highly Effective, Non-Surgical Alternative to Surgical Removal of Tonsils and Adenoids in Children LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos [...]
Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases
26/06/2025
New episode spotlights the severe burden of Netherton Syndrome in infants and children, reinforcing the need for effective pediatric treatments ASHBURN, Va., June 26, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd [...]
Ultrack Systems Inc. (OTC: MJLB) Launches “PUR Rx” — A Scalable Digital Healthcare Platform Through Joint Venture with Synergy Health Rx Corp.
26/06/2025
CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch of PUR Rx , a next-generation digital health platform formed through a 50/50 joint venture [...]
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
26/06/2025
WEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of [...]
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
26/06/2025
CUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
Aeroflow Health Launches Five-Year Corporate Philanthropy Program to Invest in Western North Carolina Communities
26/06/2025
Aeroflow’s new philanthropic giving initiative includes bold financial and volunteer commitments to healthcare, housing, and education to uplift underserved populations ASHEVILLE, N.C., June 26, 2025 (GLOBE NEWSWIRE [...]
Baylor Genetics Applauds New Guidance from American Academy of Pediatrics for Genome and Exome Sequencing to be used as First-Tier Tests for Children with Certain Developmental Delays
26/06/2025
Guidance also outlines metabolic evaluation – like Baylor Genetics’ unique Global MAPS® untargeted metabolite screen – as second-tier test HOUSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading clinical [...]
Dr. Anosh Ahmed Supports Trump’s Statement on Chicago, Citing Ongoing Public Safety and Policy Challenges
26/06/2025
Physician and Republican leader voices concern over rising crime and strained social infrastructure in the city Image by Dr. Anosh Ahmed CHICAGO, June 26, 2025 (GLOBE NEWSWIRE) -- In response to President Donald J. [...]
Longeveron® Appoints Than Powell as Chief Business Officer
26/06/2025
Mr. Powell to oversee Longeveron’s partnering and international strategy efforts MIAMI, June 26, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company [...]
SafeSpace Global Corporation Partners with Kansas City Area Transportation Authority to Enhance Safety Ahead of FIFA World Cup 2026
26/06/2025
SafeSpace AI Platform to be Piloted on Seven KCATA Buses Knoxville, TN, June 26, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTC PINK: SSGC), a global leader in AI-driven safety and monitoring solutions, is [...]
Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025
26/06/2025
Event titled “A Conversation on the Latest Results from the Ongoing Phase 1b/2a Clinical Trial of EVER001, a Next-Generation Covalent Reversible BTK Inhibitor for the Treatment of Primary Membranous Nephropathy (pMN)” [...]
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
26/06/2025
REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
26/06/2025
REYKJAVIK, ICELAND (June 26, 2025) — Alvotech (NASDAQ: ALVO, ALVO SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today [...]
World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
26/06/2025
Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE) In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary [...]
I-Mab Highlights Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
26/06/2025
71% objective response rate (ORR) (12/17) per RECIST v1.1, with a favorable safety profile 83% ORR (10/12) in patients across doses selected for ongoing dose expansion study Responses observed in patients with low PD-L1 [...]

Pages